Login

Hendrik Bischof from HUBER+SUHNER discusses his role in Group Strategy and M&A and his experiences working at the company. 00:10:00

Share On Facebook Share On Twitter

Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Gold Bull Resources: Unveiling Sandman's Potential Through Successful Exploration
00:10:00
Cofle SpA's Evolution and Future Prospects with CEO Walter Barbieri | Walter Barbieri, CEO, Cofle SpA.
00:10:00
Panel Highlights the Shift to Pre-Trade and Intra-Trade Best Execution Analysis
00:10:00
Gold Exploration in Finland's Lapland Greenstone Belt
00:10:00
Transforming Golf's Global Appeal Through Strategic Investment | Mark Attanasio, Co-Founder, Crescent Capital Group.
00:10:00
Benitec Biopharma Inc is a clinicalstage biotechnology company advancement of novel genetic medicines|Dr. Jerel Banks,Director,Benitec Biopharma Ltd
00:10:00
Navigating Safe Waters: Insights from Safe Bulkers' President on Fleet Expansion and Market Strategy
00:10:00
Robert Ogór Explores the Dynamics of the Wine Industry and Alcohol Market | Roberto Funari, CEO , Alpargatas SA.
00:10:00
Our goal is to treat cancer as well as inflammatory and autoimmune diseases|Göran Forsberg,CEO,Cantargia
00:10:00
Event-driven analysis of Temenos AG reveals extremely negative sentiments, with most sell-side analysts recommending Sell or Neutral positions.
00:10:00
Excelsior Gold presents the Kookynie North Gold Project
00:10:00
2024 Real Estate Market Outlook: Residential and Commercial Trends

© 2017 - Neuhu+